Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2010
06/30/2010CN101129727B Orally taken traditional Chinese medicine composition for treating intercostal neurodynia
06/29/2010USRE41408 pharmacokinetics; opioid addiction
06/29/2010US7745638 Anticancer agents; such as 4-acetylamino-1H-pyrazole-3-carboxylic acid (4-fluoro-phenyl)-amide
06/29/2010US7745489 Potent 2-oxo-amide based compounds; abrogating prostaglandin production; low dosage; spinal cord and central nervous system pain
06/29/2010US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
06/29/2010US7745450 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases
06/29/2010US7745447 6-(4-Chlorophenyl)-3-(5-hydroxypyridin-2-yl)thieno[3,2-d]pyrimidin-4(3H)-one, for example; for treating a patient suffering from an MCHR-1 modulated disease or disorder such as obesity, diabetes, depression or anxiety
06/29/2010US7745429 Crystal forms of olanzapine and processes for their preparation
06/29/2010US7745427 (Calcitonin gene related peptide); azepinone ligands; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide; analgesic, antiinflammatory agent; migranes, arthritis, neurodegenerative diseases
06/29/2010US7745426 vitamin B6-based component selected from pyridoxal, pyridoxamine or pyridoxine chemically linked to antiepileptic agents, neuroprotectants, neurotransmitters or nootropic agents, used for the treatment of epilepsy
06/29/2010US7745420 stability, high effectiveness and low toxicity; for treating pulmonary/respiratory diseases such as cystic fibrosis, asthma, chronic bronchitis, chronic obstructive lung disease, eosinophilic bronchitis
06/29/2010US7745388 Peptide for use in the treatment of cell damage caused by ischemia
06/29/2010US7745112 predicting a response of a human subject to a nicotine replacement treatment designed to assist smoking cessation; screening a smokers DNA for the presence and genotype of dopamine beta -hydroxylase 1368 alleles and dopamine D2 receptor Taq I RFLP alleles; nicotine replacement treatment
06/29/2010US7744933 Use of unsaponifiable components of vegetable oils for preparing a cosmetic and related treatments
06/29/2010US7744906 Chaperone proteins comprising at least one of three specific nucleotide sequences; analgesics; side effect reduction; lastslonger than narcotics; relieving any type of pain
06/29/2010CA2461576C Process for the preparation of tablets comprising s-adenosylmethionine
06/29/2010CA2455987C Tetrahydroindolone and purine derivatives linked to arylpiperazines
06/29/2010CA2455628C Neuroprotective drug comprising flibanserin
06/29/2010CA2453516C Alpha-ketoglutarates of l-carnitine and alkanoyl l-carnitine and compositions thereof
06/29/2010CA2442885C Sulphones which modulate the action of gamma secretase
06/29/2010CA2418070C Hybrid neuroprosthesis for the treatment of brain disorders
06/29/2010CA2404737C Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug
06/29/2010CA2382885C Rhodamine derivatives for photodynamic diagnosis and treatment
06/29/2010CA2357114C Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder
06/29/2010CA2354557C Methods to inactivate n-type calcium channels
06/29/2010CA2218909C Isolating and culturing schwann cells
06/29/2010CA2187740C Dna encoding bradykinin b1 receptor
06/29/2010CA2187346C Receptor modulating agents and methods relating thereto
06/29/2010CA2134030C Soluble interferon .alpha.-receptor, its preparation and use
06/24/2010WO2010071872A2 [2.2.2] bicyclic derivatives and methods of use
06/24/2010WO2010071863A1 Regeneration and repair of neural tissue following injury
06/24/2010WO2010071853A1 Thiazolopyridine sirtuin modulating compounds
06/24/2010WO2010071846A2 Compounds for treating neuropsychiatric conditions
06/24/2010WO2010071575A1 Quaternary piperidine derivatives and uses thereof
06/24/2010WO2010071567A1 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
06/24/2010WO2010070238A1 Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof
06/24/2010WO2010070237A1 Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof
06/24/2010WO2010070061A1 Compositions, kits and methods of a titration schedule for bifeprunox compounds
06/24/2010WO2010070022A1 Novel compounds
06/24/2010WO2010070008A1 Substituted bicyclic imidazole derivatives as gamma secretase modulators
06/24/2010WO2010069915A1 Medical dietary composition for treating neurodegenerative diseases
06/24/2010WO2010069605A2 Oxidized cardiolipin as a novel pro-inflammatory factor
06/24/2010WO2010069561A1 Cocrystals of tramadol and paracetamol
06/24/2010WO2010069331A2 Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders
06/24/2010WO2010069204A1 Pluripotent stem cells, method for preparation thereof and uses thereof
06/24/2010WO2010069139A1 Pharmaceutical composition and preparation method thereof
06/24/2010WO2010069138A1 Oryzanol composition and preparation method thereof
06/24/2010WO2010038948A3 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
06/24/2010WO2010036977A3 Combination therapies with topiramate for seizures, restless legs syndrome, and other neurological conditions
06/24/2010WO2010033451A3 5-oxazolidin-2-one substituted 1,3,8-triazaspiro [4.5] decan-4-one derivatives useful as orl-1 receptor modulators
06/24/2010WO2010026436A3 1,3, 4, 6, 7, 11b-hexahydro-benzo[alpha]quinolizines for the treatment of hyperkinetic movement and related disorders
06/24/2010WO2010010112A3 Construct and method for the internalization of cargo molecules into a cell
06/24/2010WO2010006772A3 Use of cd95 inhibitors for the treatment of inflammatory disorders
06/24/2010WO2010005958A3 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
06/24/2010WO2009101616A9 Novel conjugates for treating neurodegenerative diseases and disorders
06/24/2010WO2007095223A3 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases
06/24/2010US20100162422 Novel therapeutic and diagnostic products and methods
06/24/2010US20100160627 (2,3-cis)-3-amino-2-phenyl-2,3-dihydro-1,5-benzoxazepin-4(5H)-one; for treatment of neurological disorders related to amyloid beta protein production such as Alzheimer's disease; inhibit gamma secretase and thereby inhibit the production of amyloid beta protein
06/24/2010US20100160447 Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
06/24/2010US20100160443 Compounds useful for treating neurological disorders
06/24/2010US20100160436 Stable gabapentin compositions
06/24/2010US20100160433 Treatment of neurodegenerative and cardiovascular disorders
06/24/2010US20100160432 Curative drug for neurodegenerative diseases
06/24/2010US20100160411 Benzoxathiine and benzoxathiole derivatives and uses thereof
06/24/2010US20100160409 Highly Branched Reagents For Modifying Biopharmaceuticals, Their Preparation And Use
06/24/2010US20100160405 Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione
06/24/2010US20100160400 Treatment using dantrolene
06/24/2010US20100160392 Histone deacetylase inhibitors
06/24/2010US20100160390 Compounds capable of activating cholinergic receptors
06/24/2010US20100160383 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation
06/24/2010US20100160378 Compositions for drug administration
06/24/2010US20100160377 Derivatives of pyrazole 3,5-carboxylates, their preparation and their application in therapeutics
06/24/2010US20100160376 Nicotine-alternative compositions and methods of producing such compositions
06/24/2010US20100160374 N-(2-Hydroxyethyl)-N-Methyl-4-(Quinolin-8-yl(1-(Thiazol-4-ylmethyl)Piperidin-4-ylidene)Methyl)Benzamide
06/24/2010US20100160372 Treatment of proteinopathies using a farnesyl transferase inhibitor
06/24/2010US20100160364 Remedy or preventive for integration dysfunction syndrome
06/24/2010US20100160357 Heterobicyclic sphingosine 1-phosphate analogs
06/24/2010US20100160352 Adenine derivatives
06/24/2010US20100160349 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
06/24/2010US20100160346 Neurologically active compounds
06/24/2010US20100160345 Novel compounds
06/24/2010US20100160344 Novel compounds
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160337 Sulfamides as trpm8 modulators
06/24/2010US20100160334 Tricyclic anilide spirolactam cgrp receptor antagonists
06/24/2010US20100160333 Novel 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/24/2010US20100160332 a2-Adrenoceptor Ligands
06/24/2010US20100160331 Novel carbamoyloxy arylalkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/24/2010US20100160324 Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
06/24/2010US20100160320 C5aR ANTAGONISTS
06/24/2010US20100160319 Histamine h3 receptor agents, preparation and therapeutic uses
06/24/2010US20100160315 Novel 2, 3-diamino-quinazolinone derivatives and their medical use
06/24/2010US20100160295 Treatment of restless leg syndrome and sleep disorders
06/24/2010US20100160294 Tolerability of mirtazapine and a second active by using them in combination
06/24/2010US20100160291 Tricyclic spiro-oxindole derivatives and their uses as therapeutic agents
06/24/2010US20100160290 Pharmaceutical composition for treating alzheimer's disease
06/24/2010US20100160280 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
06/24/2010US20100160274 7-KETO DHEA for Psychiatric Use
1 ... 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 ... 1833